Table 3.
Multivariate Cox regression analyses for overall and cancer-specific survivals.
| Overall survival | Cancer-specific survival | |||||
|---|---|---|---|---|---|---|
| Variables | HR | 95% CI | P | HR | 95% CI | P |
| GENDER | ||||||
| Female vs. Male | 0.69 | 0.52–0.91 | 0.009 | 0.62 | 0.38–0.99 | 0.049 |
| AGE (YEARS) | ||||||
| ≥70 vs. <70 | 2.16 | 1.62–2.89 | <0.001 | 1.64 | 1.01–2.67 | 0.047 |
| LOCATION | ||||||
| Ureter vs. Renal pelvis | 1.11 | 0.83–1.49 | 0.477 | 1.01 | 0.61–1.68 | 0.976 |
| SYNCHRONOUS | ||||||
| Yes vs. No | 1.47 | 0.86–2.50 | 0.157 | 1.16 | 0.44–3.04 | 0.760 |
| PAPILLARY ARCHITECTURE | ||||||
| Yes vs. No | 0.84 | 0.62–1.14 | 0.262 | 0.78 | 0.46–1.30 | 0.334 |
| T3–T4 | ||||||
| Yes vs. No | 2.50 | 1.81–3.45 | <0.001 | 5.32 | 3.09–9.17 | <0.001 |
| NODE POSITIVE | ||||||
| Yes vs. No | 1.51 | 0.87–2.63 | 0.145 | 1.44 | 0.65–3.16 | 0.371 |
| RADIATION THERAPY | ||||||
| Yes vs. No | 1.60 | 0.64–3.99 | 0.310 | 1.34 | 0.42–4.22 | 0.620 |
| CHEMOTHERAPY | ||||||
| Yes vs. No | 1.47 | 0.91–2.38 | 0.112 | 1.77 | 0.92–3.44 | 0.090 |
HR, hazard ratio; CI, confidence interval.